2026-11-04Bullish
+13.49%24 hours changeQ3 sales of $2.063bn and adjusted EPS of $1.90 beat estimates and guidance rose, lifting shares 13.49% to $110.15.
read the report →Zimmer Biomet is a medical device company that makes orthopaedic reconstructive products such as knee and hip implants, plus sports medicine, biologics, and trauma products.
Q3 sales of $2.063bn and adjusted EPS of $1.90 beat estimates and guidance rose, lifting shares 13.49% to $110.15.
read the report →